Publication Relating to Transparency Notifications
REGULATED INFOMATION
Publication Relating to Transparency Notifications
Mont-Saint-Guibert(Belgium),April 20, 2023,10.30pm CET / 4.30pm ET ? In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below.
Together Partnership
On April 18, 2023, Nyxoah received a transparency notification from Together Partnership following the crossing of the 10% threshold by Together Partnership on March 30, 2023. As of such date, Together Partnership held 2,948,285 shares, representing 10.42% of the total number of voting rights on March 30, 2023 (28,286,985).
The notification dated April 17, 2023 contains the following information:
Reason for the notification: acquisition or disposal of voting securities or voting rights
Notification by: a person that notifies alone
Persons subject to the notification requirement: Together Partnership (with address at Van Putlei 31, 2018 Antwerp)
Date on which the threshold was crossed: March 30, 2023
Threshold that is crossed: 10%
Denominator: 28,286,985
Notified details:
A) Voting rights
Previous notification
After the transaction
# of voting rights
# of voting rights
% of voting rights
Holders of voting rights
Linked to securities
Not linked to the securities
Linked to securities
Not linked to the securities
Together Partnership
2,503,500
2,948,285
10.42%
TOTAL
2,948,285
0
10.42%
0.00%
Chain of controlled undertakings through which the holding is effectively held: Together Partnership is not a controlled entity.
ResMed Inc.
On April 18, 2023, Nyxoah received a transparency notification from ResMed Inc. following the crossing of the 5% threshold by ResMed Inc. on March 30, 2023. As of such date, ResMed Inc. held 1,499,756 shares, representing 5.30% of the total number of voting rights on March 30, 2023 (28,286,985).
The notification dated April 16, 2023 contains the following information:
Reason for the notification: acquisition or disposal of voting securities or voting rights
Notification by: a person that notifies alone
Persons subject to the notification requirement: ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA)
Date on which the threshold was crossed: March 30, 2023
Threshold that is crossed: 5%
Denominator: 28,286,985
Notified details:
A) Voting rights
Previous notification
After the transaction
# of voting rights
# of voting rights
% of voting rights
Holdersof voting rights
Linked to securities
Not linked to the securities
Linked to securities
Not linked to the securities
ResMed Inc.
794,235
1,499,756
TOTAL
1,499,756
0
5.30%
0.00%
Chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity.
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Increasing prevalence of breast cancer is...
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 10.87% during the forecast period. Increasing prevalence of chronic disorders is...
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...
The global dermatology devices market size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 9.45% during the forecast period. Increasing prevalence of skin...